HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Anil Bhanudas Gaikwad Selected Research

Kidney Diseases (Kidney Disease)

2/2024Significance of LncRNAs in AKI-to-CKD transition: A therapeutic and diagnostic viewpoint.
11/2023Metabolic reprogramming: Unveiling the therapeutic potential of targeted therapies against kidney disease.
9/2023Toll-like receptors 2 and 4 stress signaling and sodium-glucose cotransporter-2 in kidney disease.
6/2023Concomitant inhibition of TLR-4 and SGLT2 by phloretin and empagliflozin prevents diabetes-associated ischemic acute kidney injury.
1/2023Promising novel therapeutic targets for kidney disease: Emphasis on kidney-specific proteins.
1/2023How to use COVID-19 antiviral drugs in patients with chronic kidney disease.
1/2023Klotho in kidney diseases: a crosstalk between the renin-angiotensin system and endoplasmic reticulum stress.
1/2022Epigenetic regulation of Toll-like receptors 2 and 4 in kidney disease.
1/2021Epigenetic and non-epigenetic regulation of Klotho in kidney disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Anil Bhanudas Gaikwad Research Topics

Disease

15Diabetic Nephropathies (Diabetic Nephropathy)
05/2023 - 01/2009
14Inflammation (Inflammations)
11/2023 - 04/2016
12Fibrosis (Cirrhosis)
05/2023 - 10/2015
9Kidney Diseases (Kidney Disease)
02/2024 - 01/2021
9Insulin Resistance
01/2024 - 05/2007
8Acute Kidney Injury (Acute Renal Failure)
04/2024 - 02/2019
5Diabetes Complications
02/2024 - 01/2021
5Diabetic Cardiomyopathies
10/2019 - 09/2017
4Heart Failure
04/2024 - 03/2007
4Hyperglycemia
02/2024 - 05/2007
4Hypoxia (Hypoxemia)
02/2024 - 01/2022
4Reperfusion Injury
02/2024 - 01/2022
4Obesity
12/2023 - 04/2016
4Type 1 Diabetes Mellitus (Autoimmune Diabetes)
06/2023 - 05/2015
4Chronic Renal Insufficiency
01/2023 - 06/2017
4Neoplasms (Cancer)
01/2020 - 12/2016
4Renal Insufficiency (Renal Failure)
11/2017 - 03/2010
4Type 2 Diabetes Mellitus (MODY)
10/2015 - 03/2010
2Mitochondrial Diseases (Mitochondrial Disease)
02/2024 - 11/2023
2Hyperinsulinism (Hyperinsulinemia)
12/2023 - 05/2015
2Hypertension (High Blood Pressure)
12/2023 - 10/2023
2Lupus Nephritis
10/2023 - 07/2023
2Ischemia
06/2023 - 09/2020
2COVID-19
01/2023 - 01/2020
2Necrosis
01/2021 - 10/2017
2Diabetes Mellitus
12/2020 - 10/2019
2Cardiomyopathies (Cardiomyopathy)
09/2017 - 03/2010
2Atherosclerosis
06/2017 - 04/2016
2Hypertrophy
03/2010 - 01/2009
1Hematologic Neoplasms (Hematological Malignancy)
12/2023
1Dyslipidemias (Dyslipidemia)
12/2023
1Epilepsy (Aura)
10/2023
1Systemic Lupus Erythematosus (Libman-Sacks Disease)
07/2023

Drug/Important Bio-Agent (IBA)

8esculetinIBA
04/2024 - 05/2015
8Proteins (Proteins, Gene)FDA Link
09/2023 - 08/2017
8Streptozocin (Streptozotocin)FDA Link
06/2023 - 05/2007
8Histones (Histone)IBA
12/2020 - 03/2010
7Glucose (Dextrose)FDA LinkGeneric
02/2024 - 05/2007
7Telmisartan (Micardis)FDA Link
03/2023 - 04/2010
4PhloretinIBA
04/2024 - 06/2023
4Angiotensin-Converting Enzyme 2IBA
03/2022 - 11/2015
4MicroRNAs (MicroRNA)IBA
01/2022 - 01/2019
4Neprilysin (Neutral Endopeptidase)IBA
10/2019 - 01/2019
4Insulin (Novolin)FDA Link
06/2017 - 05/2007
3Type 1 Angiotensin ReceptorIBA
04/2024 - 03/2023
3Biomarkers (Surrogate Marker)IBA
02/2024 - 01/2021
3Sodium AzideIBA
02/2024 - 06/2023
3SodiumIBA
09/2023 - 02/2019
3HMGB1 Protein (HMG1)IBA
09/2023 - 01/2022
3Angiotensin Receptor AntagonistsIBA
01/2023 - 11/2017
3AntioxidantsIBA
11/2020 - 08/2017
3Type 2 Angiotensin ReceptorIBA
09/2020 - 10/2017
3Fibronectins (Fibronectin)IBA
09/2017 - 01/2015
3Angiotensin IIIBA
04/2016 - 05/2007
2coumarinIBA
02/2024 - 12/2016
2Peroxisome Proliferator-Activated Receptors (PPAR)IBA
01/2024 - 01/2015
2Toll-Like Receptor 4IBA
11/2023 - 01/2022
2Sodium-Glucose Transporter 2 InhibitorsIBA
09/2023 - 06/2023
2Toll-Like Receptors (Toll-Like Receptor)IBA
09/2023 - 01/2022
2Ligases (Synthetase)IBA
05/2023 - 04/2016
2SirtuinsIBA
01/2023 - 03/2007
2EnzymesIBA
08/2022 - 06/2018
2CytokinesIBA
08/2022 - 01/2021
2Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2021 - 01/2015
2Interleukin-6 (Interleukin 6)IBA
01/2021 - 10/2017
2Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
10/2019 - 11/2015
2ThiorphanIBA
03/2019 - 01/2019
2Natriuretic PeptidesIBA
03/2019 - 01/2019
2Caspase 3 (Caspase-3)IBA
01/2019 - 10/2017
2Angiotensin Receptors (Angiotensin II Receptor)IBA
01/2019 - 12/2016
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
06/2018 - 04/2010
2compound 21IBA
11/2017 - 10/2017
2Peptides (Polypeptides)IBA
11/2017 - 10/2017
2Lysine (L-Lysine)FDA Link
10/2017 - 12/2016
2CollagenIBA
08/2017 - 01/2015
2ChromatinIBA
12/2016 - 06/2010
1Valsartan (Vals)FDA Link
04/2024
1sacubitrilIBA
04/2024
1Immunosuppressive Agents (Immunosuppressants)IBA
03/2024
1Facilitative Glucose Transport Proteins (Glucose Transporter)IBA
01/2024
1DecitabineFDA Link
12/2023
1Azacitidine (5 Azacytidine)FDA Link
12/2023
1Amino AcidsFDA Link
11/2023
1Losartan (Cozaar)FDA LinkGeneric
11/2023
1belimumabIBA
10/2023
1voclosporinIBA
10/2023
1Carrier Proteins (Binding Protein)IBA
09/2023
1InflammasomesIBA
09/2023
1AutoantigensIBA
07/2023
1Hypoglycemic Agents (Hypoglycemics)IBA
06/2023
1empagliflozinIBA
06/2023
1SymportersIBA
06/2023
1ursodoxicoltaurineIBA
03/2023
1Phosphotransferases (Kinase)IBA
01/2023
1ApelinIBA
01/2023
1UromodulinIBA
01/2023
1Cannabinoid Receptors (Cannabinoid Receptor)IBA
01/2023

Therapy/Procedure

18Therapeutics
04/2024 - 08/2017
2Drug Therapy (Chemotherapy)
06/2017 - 04/2010
1Glycemic Control
12/2023